tcptrace-bugs Before the Bell: (TDST) Enabling the Telemedical Revolution.

From: The Savvy Investor Newsletter (
Date: 10/09/03

Message-ID: <000021381931$00007a08$>
From: "The Savvy Investor Newsletter" <>
Subject: tcptrace-bugs Before the Bell: (TDST) Enabling the Telemedical Revolution.
Date: Thu, 09 Oct 2003 03:11:03 -0500

October 2003 Edition of The Savvy Investor
Each month The Savvy Investor analysts study, research, and examine hundreds of stocks, in an effort to pinpoint the one with the most promise. 

This month s pick : TDS Telemedicine, Inc.

Symbol: TDST

Recent Price: $.08 

Opinion: Strong Buy

In Related News:
 Health care providers are getting wired up for a future where every patient's medical record is a click away and doctors assist one another in operations thousands of miles apart via video conferencing. More...

      A new approach to healthcare around the globe is on its way, according to experts at the World Economic Forum.. More....

     TDS Telemedicine CEO Roger Coomber and Chief Medical Officer Keith Freeman Interviewed. Video


Financial Analysis

Confirmation has been received for a total contribution apportioned between County and Medicaid of US $550,000 in 2003.

With funding approval in place, as well as anticipated additional equity funding over the next few months, TDS expects the following financial performance:

2003      Revenues      $1.0 million
          Net Pre-tax   $100,000

2004      Revenues      $13.5 million
          Net Pre-tax   $3.4 million

2005      Revenues      $22.0 million
          Net Pre-tax   $6.25 million
Corporate Snapshot

TDS Telemedicine Inc is the parent Company of an established UK based firm, TDS Dermatology Ltd. For the past 5 years this Company has provided comprehensive dermatology telemedicine to the National Health Service in England. Over 25,000 telemedical consultations have been performed since the Company commenced operations, making it the world's largest telemedical dermatology provider.

The tendency to cut jobs in favor of profits is a driving force in the economy. When workers are more productive, fewer workers are needed. Telemedicine is the logical extension of this notion as it applies to the health care industry, a field with the highest concentration of top paying jobs in the country. Now utilizing telemedical technology, a single health care professional can see multiple patients in almost any location, even in the patients' homes. This means maximum productivity for medical personnel, lower capital expenses for the companies that employ them and the added convenience of "house calls" for the patients. TDS services will go live later this month in Texas as planned. Discussions have commenced in other US states and it is expected that TDST's nationwide roll-out program will go into effect quickly.



Analyst Conclusion

The recent SEC ruling to leave the Over The Counter Bulletin Board in its current form is a very bullish sign for this market - possibly a turning point. We think that this is an encouraging signal from regulators that the OTCBB can expect a more positive financial climate. We assessed TDST and found 4 basic investment criteria.

1. The market is in a confirmed rally.
2. TDST is in a leading group.
3. The company financials are strong.
4. TDST is offered at an ideal Buy Point.

I would expect great things from this company and in my opinion it is a Strong Buy.

Editing Chairman

Click Here to view our disclaimer or to change your email preferences.


This archive was generated by hypermail 2.1.7 : 10/09/03 EDT